Indrayani Biotech Ltd

Indrayani Biotec's historical performance has been volatile, with net sales declining from 166.23 Cr in March 2024 to 130.23 Cr in March 2025, resulting in significant losses, including a profit after tax of -6.11 Cr in March 2025 compared to 10.42 Cr the previous year. The company's earnings per share also fell from 1.4 to -1.34 during this period.

Indrayani Biotech's latest results are concerning, with a 7.71% decline in net sales and significant drops in profitability, including an 81.18% reduction in Profit After Tax. The company faces operational challenges, liquidity issues, and increased reliance on debt.

As of 13-Nov, Indrayani Biotech Ltd's stock price is 14.78, down 1.92%, and has declined 65.14% over the past year. The stock is underperforming compared to the broader market, with significantly reduced investor interest and mixed short-term momentum indicators.

As of 06-Nov, Indrayani Biotech Ltd's stock price is at 15.60, having increased by 9.4% recently. Despite strong short-term gains, the stock remains down 57.12% year-to-date, indicating significant underperformance compared to the Sensex.

As of 27-Oct, Indrayani Biotech Ltd's stock price is Rs 13.86, down 7.41%, with significant declines over the past week and year-to-date. The stock's poor performance is attributed to negative sector sentiment and reduced investor participation.

As of 15-Oct, Indrayani Biotech Ltd's stock price is 15.52, up 5.08% with strong recent performance and increased investor interest. However, it has significant long-term declines, raising concerns about its viability despite recent positive trends.

As of 13-Oct, Indrayani Biotech Ltd's stock price is at 13.19, up 7.94% over two days, but down 63.74% year-to-date. Despite recent gains, its long-term performance is poor compared to the Sensex, and investor participation has significantly declined.

As of 30-Sep, Indrayani Biotech Ltd's stock price is 12.25, down 2.39%, and has underperformed significantly with a 66.33% decline year-to-date. The stock is facing a bearish trend due to decreasing investor interest and poor performance relative to the broader market.

As of 24-Sep, Indrayani Biotech Ltd's stock price is at 13.19, showing a short-term upward trend with a 16.62% return over the last three days, despite a significant year-to-date decline of 63.74%. The stock has recently outperformed its sector and the benchmark Sensex, indicating potential recovery, though it remains below longer-term moving averages.

As of 23-Sep, Indrayani Biotech Ltd is currently priced at 13.00, reflecting a recent increase of 2.93% and a notable 14.94% gain over the last two days. Despite this short-term positive trend, the stock has significantly underperformed year-to-date, with a decline of 64.27% compared to the Sensex's gain of 5.07%.

As of 22-Sep, Indrayani Biotech Ltd's stock price is Rs 12.63, up 11.67% today after two days of decline, but it has a year-to-date loss of 65.28%. Despite a short-term gain, its long-term performance is significantly weaker compared to the benchmark Sensex.

As of 19-Sep, Indrayani Biotech Ltd's stock price is declining at 11.31, down 3.74%, with a year-to-date drop of 68.91%. The stock is underperforming significantly compared to the market and sector, with reduced investor interest indicated by a 58.19% drop in delivery volume.

As of 18-Sep, Indrayani Biotech Ltd's stock price is at 11.75, down 1.26%, and trading below all key moving averages, indicating a bearish trend. The company has reported negative results for five consecutive quarters, with a year-to-date decline of 67.70%, reflecting weak financial performance and declining investor interest.

As of 16-Sep, Indrayani Biotech Ltd's stock price is declining at 11.79, down 1.42%, and has dropped 4.3% over the last two days. The stock is underperforming against the market, trading below all key moving averages, with significant decreases in delivery volume and poor historical returns.

As of 15-Sep, Indrayani Biotech Ltd's stock price is 11.96, down 2.92%, and trading below all key moving averages, indicating a bearish trend. The company has faced five consecutive quarters of negative results and a significant year-to-date decline of 67.12%, reflecting weak fundamentals and reduced institutional confidence.

As of 12-Sep, Indrayani Biotech Ltd's stock price is at 12.32, showing a slight increase today but a significant decline of 66.14% year-to-date and 73.39% over the past year. Despite a recent uptick in trading volume, the stock underperforms compared to the Sensex and has struggled over the longer term.

As of 11-Sep, Indrayani Biotech Ltd's stock price is at 12.23, down 1.45%. The stock has significantly underperformed over the long term, with a year-to-date decline of 66.38% and negative results for five consecutive quarters, indicating weak fundamentals and waning investor confidence.

As of 10-Sep, Indrayani Biotech Ltd's stock price is at 12.41, having increased by 1.39% recently. Despite short-term gains, the company faces significant long-term challenges, including negative profit trends and high debt, leading to diminished investor confidence.

As of 09-Sep, Indrayani Biotech Ltd's stock price is at 12.24, showing a recent increase but significant long-term underperformance with a -66.36% return year-to-date. The stock is classified as a strong sell due to ongoing challenges, including negative quarterly results and a high Debt to EBITDA ratio.